LED Medical Diagnostics Announces Closing of Prospectus Offering of Units

VANCOUVER, BC--(Marketwired - November 25, 2015) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) is pleased to announce the closing of its previously-announced best efforts agency prospectus offering under which LED has issued 11,805,544 units of the Company (the "Units") at a price of CDN$0.18 per Unit. Each Unit consists of one common share and one-half of one common share purchase warrant, with each whole warrant entitling the holder to acquire one common share of LED at a price of US$0.20 for a period of two years after the date of issuance.

The offering was completed through Bloom Burton & Co. Limited, as agent, together with a selling group consisting of registered dealers. In connection with the offering, LED has paid a cash commission of CDN$120,749.86 and LED has issued 670,832 non-transferable broker warrants. Each broker warrant is exercisable into one common share of LED at a price of US$0.20 per share for a period of two years after the date of issuance.

The proceeds of the offering are intended for working capital purposes including the purchase of inventory.

LED has received conditional approval from the TSX Venture Exchange to list the common shares, including the common shares underlying the warrants and broker warrants.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities within the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended ("U.S. Securities Act"), or any state securities laws and may not be offered or sold in the United States except in compliance with exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope^® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.